# Barclays plc: financial statements, quarterly

BCS · NYSE · CIK 312069 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bcs.md) · [Financials](/companies/bcs/financials.md) · [Filings](/companies/bcs/filings.md) · [Insiders](/companies/bcs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bcs/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [78.5](/filings/0001193125-18-086766.md) | [144](/filings/0001562762-20-000049.md) | [144](/filings/0001562762-20-000049.md) | [186](/filings/0001562762-21-000043.md) | [194](/filings/0000312069-22-000085.md) | [167](/filings/0000312069-23-000046.md) | [210](/filings/0000312069-24-000026.md) | [259](/filings/0000312069-25-000114.md) | [279](/filings/0000312069-26-000004.md) | [248](/filings/0000312069-26-000004.md) | [236](/filings/0000312069-26-000004.md) | [256](/filings/0000312069-26-000004.md) |
| Total assets | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1,384](/filings/0000312069-22-000085.md) | not reported | not reported | not reported | not reported |
| Total liabilities | $bn | not reported | [1,054](/filings/0001193125-18-086766.md) | [1,142](/filings/0001193125-19-046499.md) | [1,067](/filings/0001193125-19-046499.md) | [1,070](/filings/0001562762-20-000049.md) | [1,075](/filings/0001562762-21-000043.md) | [1,283](/filings/0000312069-22-000085.md) | [1,314](/filings/0000312069-24-000026.md) | [1,444](/filings/0000312069-25-000114.md) | [1,406](/filings/0000312069-26-000004.md) | [1,446](/filings/0000312069-26-000004.md) | [1,466](/filings/0000312069-26-000004.md) |
| Shareholders' equity | $bn | [66.0](/filings/0001193125-18-086766.md) | [59.8](/filings/0001193125-18-086766.md) | [64.9](/filings/0001193125-19-046499.md) | [63.9](/filings/0001193125-19-046499.md) | [62.6](/filings/0001562762-20-000049.md) | [64.4](/filings/0001562762-21-000043.md) | [65.8](/filings/0000312069-22-000085.md) | [69.1](/filings/0000312069-23-000046.md) | [68.3](/filings/0000312069-24-000026.md) | [71.2](/filings/0000312069-25-000114.md) | [71.8](/filings/0000312069-26-000004.md) | [77.8](/filings/0000312069-26-000004.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 13,866,661,730 at 2025-12-31, from the cover of the [20-F filed 2026-02-10](/filings/0000312069-26-000004.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.